NANBIOSIS to participate in latest Transfiere 2025, the leading innovation Forum in EU

Malaga, march 2025. NANBIOSIS, the Singular Scientific-Technical Infrastructure (ICTS) specialized in biomaterials, nanomedicine, and bioengineering, will be present at Transfiere 2025, the European Forum for Science, Technology, and Innovation. The event will take place on March 12, 13, and 14, 2025, at FYCMA (Trade Fairs and Congress Center of Málaga).

A key event for R&D, innovation and knowledge transfer

Transfiere is the largest professional and multi-sector forum for knowledge transfer and R&D&I in Southern Europe. It brings together research centers, universities, public institutions, and leading companies to foster collaboration, drive innovation, and promote technological development on an international scale.

NANBIOSIS at Transfiere 2025

The NANBIOSIS stand will be located in the Government of Spain area, alongside other ICTS, the Spanish Research Agency, and the Centre for the Development of Technology and Innovation (CDTI). NANBIOSIS representatives will be available to showcase the infrastructure’s capabilities, highlight its latest projects, and explore potential collaborations with industry partners and research institutions.

Meet us at Transfiere

Visitors to the event will have the opportunity to learn more about NANBIOSIS’ state-of-the-art services, discuss potential partnerships, and engage with experts in nanomedicine, bioengineering, and advanced biomaterials.

For more information and registration, visit: Transfiere 2025 Official Website

What is NANBIOSIS?

The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).

Leading scientists

The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.

Custom solutions

Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities

Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.

Standards of quality

Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.

In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them: